Albemarle Stock Forecast for 2022 - 2025 - 2030
Updated on 05/19/2022
Year-long price target forecasts from seven prominent analysts have recently been released for Albemarle, with an average price target of $282.50. This potential gain of 19.71 percent from the previous closing price in May, 2022 is calculated on a high forecast of $368.00 and a low estimate of $135.00. If you're looking for Albemarle (ALB) stock information, you might also want to check out FMC (NYSE:FMC).
19.71% Upside
Albemarle Price Forecast for 2022 - 2025 - 2030
In the past three years, Albemarle's Price has seen a medium drop, from $141.99 to $104.68 – a moderate 26.28% decrease. In the next year, analysts believe that Price will reach an impressive $160.12 – an increase of 52.97% For the next nine years, the forecast is for Price to grow by 493.07%
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|---|---|---|---|---|---|---|
| HON Stock Forecast | Honeywell International | Outperform |
4
|
$193.87 | $225.30 | 13.48% | 6 |
| SIE Stock Forecast | Siemens | Outperform |
3
|
113.62€ | 167.08€ | 49.62% | 10 |
| 386 Stock Forecast | China Petroleum & Chemical | Outperform |
3
|
HK$3.96 | HK$4.46 | 2.02% | 6 |
| SU Stock Forecast | Schneider Electric | Outperform |
3
|
126.22€ | 153.14€ | 30.72% | 10 |
| SHW Stock Forecast | Sherwin Williams | Outperform |
0
|
$259.66 | $304.75 | 18.04% | 0 |
Albemarle Revenue Forecast for 2022 - 2025 - 2030
In the past three years, Albemarle's Revenue has seen a tiny drop, from $3374.95 to $3327.96 – a small 1.39% decrease. In the next year, analysts believe that Revenue will reach a reasonable $4412.92 – an increase of 32.6% For the next nine years, the forecast is for Revenue to grow by 213.21%
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|---|---|---|---|---|---|---|
| ABBN Stock Forecast | ABB Ltd | Hold |
2
|
CHF32.22 | CHF36.55 | 17.54% | 6 |
| 4063 Stock Forecast | Shin-Etsu Chemical | Outperform |
3
|
¥19.69k | ¥0.00 | 21.89% | 0 |
| EMR Stock Forecast | Emerson Electric | Outperform |
4
|
$83.56 | $110.43 | 31.64% | 10 |
Albemarle Dividend per Share Forecast for 2022 - 2025 - 2030
In three years, DPS for Albemarle has grown by a respectable 16.42%, going from $1.34 to $1.56. In the coming year, analysts are expecting a small increase in DPS, predicting it will reach $1.57 – an increase of 0.64%. Over the next nine years, experts anticipate that DPS growth for Albemarle will be 39.1%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|---|---|---|---|---|---|---|
| BAS Stock Forecast | BASF | Outperform |
5
|
49.86€ | 78.27€ | 28.36% | 16 |
| LONN Stock Forecast | Lonza Group Ltd | Outperform |
3
|
CHF607.00 | CHF756.46 | 30.97% | 5 |
| LYB Stock Forecast | LyondellBasell Industries N.V. | Outperform |
6
|
$110.31 | $111.20 | 8.78% | 17 |
Albemarle Free Cash Flow Forecast for 2022 - 2025 - 2030
Over the last three years, Albemarle's Free Cash Flow has increased by 296.18%, going from $-153.82 to $-609.41. In the next year, analysts are expecting a moderate increase in EPS, predicting it will reach $-892.29 – an increase of 46.42%. In 2030, professionals predict that Albemarle's Free Cash Flow will decrease by 500.74%, to $2442.18.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|---|---|---|---|---|---|---|
| GIVN Stock Forecast | Givaudan | Hold |
3
|
CHF4.04k | CHF4.11k | -0.97% | 15 |
| A051910 Stock Forecast | LG Chem | Buy |
5
|
₩643.00k | ₩1.13M | 39.97% | 17 |
| PPG Stock Forecast | PPG Industries | Outperform |
5
|
$119.56 | $159.75 | 35.5% | 20 |
Albemarle Net Income Forecast for 2022 - 2025 - 2030
In the previous three, Albemarle's Net Income has fallen from $693.56 to $123.67. – a staggering 82.17% decrease. In the next year, analysts predict that Net Income will reach an impressive $723.49 – an increase of 485.02%. For the next nine years, the forecast is for Net Income to grow by 2166.61%
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|---|---|---|---|---|---|---|
| DSM Stock Forecast | Koninklijke DSM N.V. | Outperform |
4
|
159.55€ | 178.47€ | 16.26% | 13 |
| 002460 Stock Forecast | Ganfeng Lithium | Buy |
3
|
¥123.68 | ¥206.45 | 34.22% | 0 |
| EMSN Stock Forecast | EMS-CHEMIE HOLDING | Hold |
3
|
CHF910.00 | CHF962.67 | 9.89% | 3 |
Albemarle EBITDA Forecast for 2022 - 2025 - 2030
In the past three years, Albemarle's EBITDA has decreased by 11.19%, going from $955.66 to only $848.69. For next year, the 17.00 analysts predict earnings per share of $1240.33, which would mean an increase of 46.15%. Over the next nine years, the pros' prediction is EBITDA of $3909.29, which would mean a 9-year growth forecast of 360.63%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|---|---|---|---|---|---|---|
| NZYM B Stock Forecast | Novozymes A/S | Hold |
3
|
kr391.60 | kr445.76 | 26.92% | 11 |
| AKZA Stock Forecast | Akzo Nobel N.V. | Outperform |
4
|
93.92€ | 113.10€ | 15.52% | 13 |
| 002466 Stock Forecast | Tianqi Lithium | Outperform |
0
|
¥78.11 | ¥112.12 | 40.83% | 1 |
Albemarle EBIT Forecast for 2022 - 2025 - 2030
In the past three years, ALB's EBIT has decreased from $754.97 to $594.69 – a 21.23% drop. In the next year, analysts expect EBIT to reach an impressive $909.91 – an increase of 53.01%. For the next nine years, the forecast is for EBIT to grow by 504.9%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|---|---|---|---|---|---|---|
| SY1 Stock Forecast | Symrise | Hold |
3
|
102.95€ | 117.77€ | 15.1% | 9 |
| ICL Stock Forecast | ICL Group Ltd | Buy |
3
|
₪29.47 | ₪7.98 | -59.52% | 2 |
| FMC Stock Forecast | FMC | Outperform |
6
|
$118.69 | $123.73 | 23.01% | 7 |
Albemarle EPS Price Prediction Forecast for 2022 - 2025 - 2030
In the past three years, Albemarle's EPS has seen a medium drop, from $5.48 to $4.04 – a moderate 26.28% decrease. In the next year, analysts believe that EPS will reach an impressive $6.18 – an increase of 52.97% For the next nine years, the forecast is for EPS to grow by 493.07%
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|---|---|---|---|---|---|---|
| EMN Stock Forecast | Eastman Chemical | Outperform |
7
|
$104.22 | $139.22 | 21.86% | 9 |
| EVK Stock Forecast | Evonik Industries | Hold |
3
|
25.85€ | 31.62€ | 23.79% | 15 |
| SOL Stock Forecast | Sasol | Outperform |
0
|
R326.05 | R273.30 | 32.5% | 3 |